DRREDDY's weekly return of 1.75% was modest, but its high volatility of 28.64% suggests a tumultuous ride for investors. Compared to its peers, DRREDDY underperformed DIVISLAB and SUNPHARMA, but outperformed HINDUNILVR. The stock's Sharpe Ratio of 0.33 indicates a relatively low risk-adjusted return, and its Max Drawdown of -1.49% suggests a moderate level of risk. Overall, DRREDDY's weekly performance was lackluster, with high volatility making it a relatively risky bet.

[Volatility: 28.64%]